scholarly journals Genome Editing of Human Embryos and Creation of Human Embryos for Research in Japan: A Human Rights Perspective

2020 ◽  
Vol 25 (10) ◽  
pp. 10_40-10_45
Author(s):  
Hiroko TATElSHI
2019 ◽  
Vol 2 (5) ◽  
pp. 293-298 ◽  
Author(s):  
Jodi Halpern ◽  
Sharon E. O'Hara ◽  
Kevin W. Doxzen ◽  
Lea B. Witkowsky ◽  
Aleksa L. Owen
Keyword(s):  

2019 ◽  
Vol 62 (8) ◽  
pp. 103682 ◽  
Author(s):  
Joyce C. Harper ◽  
Gerald Schatten
Keyword(s):  

1997 ◽  
Vol 4 (2) ◽  
pp. 73-77 ◽  
Author(s):  

AbstractThe recent debate on the theoretical possibility of cloning human beings is urging society to develope a global legal barrier in order to prohibit the use of this technique on humans. Some national legislation, e.g. Germany, already bans the cloning of human beings. The European Convention on Human Rights and Biomedicine contains three articles which together form the cornerstones for a prohibition of cloning: Article 1 guarantees the identity of human beings, Article 18.2 explicitly prohibits the creation of human embryos for research purposes and Article 13 contains a prohibition on the modification of the genome of any decendants. The prohibition of cloning human beings in the Protocol on Embryo Protection foreseen by the Council of Europe seems a necessary consequence. Furthermore, the forthcoming UNESCO Declaration on the Human Genome and Human Rights should contain such an explicit prohibition.


2021 ◽  
pp. 199-209
Author(s):  
Branislav Fabry

The article deals with the contemporary legal and ethical challenges, caused by coronavirus COVID-19. It analyses the reason why the western world was so much surprized by that pandemics. The text mentions the succeses of western medicine in the battle against epidemics in the 20th century and sees it as one of the reason for underestimating the public health issues in 21st century. The article also emphasizes on other contemporary threat, the antimicrobiotic resistance and the need for new legal answers to pandemics. It deals with problem of human genome editing as the central topic by creating of hereditary immunity against new viral threats. The text also mentions the risks of such new treatment and the impact on human dignity that is understood as leading value in the contemporary legal regulation on biotechnology.


2018 ◽  
Vol 17 (03) ◽  
pp. C02 ◽  
Author(s):  
Angela Simone

Responsible Research and Innovation (RRI) is gaining momentum worldwide and is envisaged as a needed tool to properly govern controversial innovative technology (i.e. genome editing, AI). Europe is considered a leader in fostering such approach, notably through its institutionalization. Even so, the future of European Research and Innovation (R&I) seems to be designed without a central role for RRI. After long effort and so much public EU money to support projects to ground RRI principles and practices in key contexts for the flourishing of science and technology in Europe, such as the industrial realm and regional settings, this counter-intuitive decision could undermine the leadership of Europe in prioritizing civil and human rights and needs, values and expectations of its citizens when steering science and technology, that European R&I strongly need to go further.


Sign in / Sign up

Export Citation Format

Share Document